ENO1 and glioma: Using this concept of collateral lethality, we validated that in a subset of gliomas with 1p36 deletions, passenger deletion of the glycolytic gene ENO1 selectively renders cancer cells sensitive to inhibition of the redundant isoform ENO2 [8].